Unicycive Therapeutics (UNCY) Inventory (2024 - 2026)

Unicycive Therapeutics' (UNCY) quarterly Inventory came in at $7.7 million in Q1 2026, up 24.24% on a QoQ basis from $6.2 million in Q4 2025.

Unicycive Therapeutics (UNCY) Inventory (2024 - 2026) Analysis & Trends

Unicycive Therapeutics (UNCY) has 3 years of Inventory data on file, last reported at $7.7 million in Q1 2026.

Quarterly Inventory changed N/A year-over-year to $7.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.7 million (changed N/A YoY) and the FY2025 annual result came in at $6.2 million, up 71.73% from the prior year.
Inventory rose to $7.7 million in Q1 2026, from $6.2 million in the prior quarter.
In the past five years, Inventory ranged from a high of $7.7 million in Q1 2026 to a low of $3.6 million in Q4 2024.
A 3-year average of $5.8 million and a median of $6.2 million in 2025 frame the typical range for Inventory.
The widest YoY moves for Inventory: up 71.73% in 2025, down 71.73% in 2025.
Tracing UNCY's Inventory over 3 years: stood at $3.6 million in 2024, then soared by 71.73% to $6.2 million in 2025, then advanced by 24.24% to $7.7 million in 2026.
The last three Inventory figures came in at $7.7 million (Q1 2026), $6.2 million (Q4 2025), and $3.6 million (Q4 2024), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Inventory (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	1.77 Bn
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	3.08 Bn
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	371.00 Mn
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	280.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	732.60 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	97.11 Mn
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	128.86 Mn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	142.38 Mn
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Unicycive Therapeutics	151.01 Mn	151.01 Mn	-	7.60 Mn

Download Data